CACNA1D Gene Primary Aldosteronism Seizures and Neurologic Abnormalities Genetic Test sale cost 4400 AED
NPHS1 Gene Nephrosis Finnish Type Genetic Test sale cost 4400 AED NPHS1 Gene Nephrosis Finnish Type Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
SCNN1B Gene Pseudohypoaldosteronism type 1 autosomal recessive Genetic Test sale cost 4400 AED SCNN1B Gene Pseudohypoaldosteronism type 1 autosomal recessive Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

CACNA1D Gene Primary Aldosteronism Seizures and Neurologic Abnormalities Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “CACNA1D Gene Primary Aldosteronism Seizures and Neurologic Abnormalities Genetic Test” is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the CACNA1D gene. These mutations are known to be associated with a spectrum of clinical manifestations, including primary aldosteronism, seizures, and various neurologic abnormalities. Primary aldosteronism is a condition characterized by the overproduction of the hormone aldosterone by the adrenal glands, leading to high blood pressure and low potassium levels. The CACNA1D gene encodes the alpha-1D subunit of a voltage-dependent calcium channel, crucial for the regulation of aldosterone production and neuronal excitability. Mutations in this gene can disrupt these processes, resulting in the aforementioned symptoms.

This genetic test is crucial for individuals presenting with a combination of endocrine and neurological symptoms, as it can confirm the genetic basis of their condition, guiding more personalized and effective treatment strategies. The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for specific mutations in the CACNA1D gene.

Offered at a cost of 4400 AED, the test is conducted at DNA Labs UAE, a facility known for its advanced genetic testing services. The price reflects the comprehensive nature of the test, including the sophisticated technology and expertise required to accurately identify mutations in the CACNA1D gene. By providing this test, DNA Labs UAE plays a crucial role in the diagnosis and management of patients with rare genetic conditions associated with the CACNA1D gene, ultimately contributing to improved patient outcomes.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CACNA1D Gene Primary Aldosteronism Seizures and Neurologic Abnormalities Genetic Test

Are you experiencing symptoms of primary aldosteronism, seizures, or neurologic abnormalities? DNA Labs UAE offers a comprehensive genetic test to help diagnose these conditions and guide appropriate treatment or management strategies. Our CACNA1D Gene Primary Aldosteronism Seizures and Neurologic Abnormalities Genetic Test is designed to analyze the CACNA1D gene, which is associated with these conditions.

Test Details

The CACNA1D gene is linked to primary aldosteronism, seizures, and neurologic abnormalities. Primary aldosteronism is characterized by the overproduction of aldosterone hormone, leading to high blood pressure and low potassium levels. Seizures are abnormal electrical activity in the brain that can cause changes in behavior, movements, or consciousness. Neurologic abnormalities refer to any dysfunction or abnormality in the nervous system, which can manifest as developmental delays, movement disorders, or cognitive impairments.

Our Next-Generation Sequencing (NGS) technology allows us to analyze multiple genes simultaneously to identify genetic variations or mutations. In the case of the CACNA1D gene, our NGS genetic testing can identify any variations or mutations that may be associated with primary aldosteronism, seizures, or neurologic abnormalities.

Test Components and Price

Our CACNA1D Gene Primary Aldosteronism Seizures and Neurologic Abnormalities Genetic Test is priced at AED 4400.0. The test can be conducted using a blood sample, extracted DNA, or one drop of blood on an FTA card.

Report Delivery and Method

Once the test is conducted, the report will be delivered within 3 to 4 weeks. Our method of analysis is NGS technology, ensuring accurate and comprehensive results.

Referring Doctor and Test Department

If you are considering this test, we recommend consulting with a General Physician. Our test department specializes in Genetics and will ensure the highest quality of analysis and interpretation.

Pre Test Information and Genetic Counselling

Before undergoing the CACNA1D Gene Primary Aldosteronism Seizures and Neurologic Abnormalities Genetic Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected by these conditions. This will aid in the accurate interpretation of the test results and provide valuable insights into the genetic factors involved.

Don’t wait any longer to find answers to your symptoms. Contact DNA Labs UAE today to schedule your CACNA1D Gene Primary Aldosteronism Seizures and Neurologic Abnormalities Genetic Test and take control of your health.

Test Name CACNA1D Gene Primary aldosteronism seizures and neurologic abnormalities Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Hepatology Nephrology Endocrinology Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CACNA1D Gene Primary aldosteronism, seizures, and neurologic abnormalities NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CACNA1D Gene Primary aldosteronism, seizures, and neurologic abnormalities NGS Genetic DNA Test gene CACNA1D
Test Details

The CACNA1D gene is associated with primary aldosteronism, seizures, and neurologic abnormalities. Primary aldosteronism is a condition characterized by the overproduction of aldosterone hormone by the adrenal glands, leading to high blood pressure and low potassium levels. Seizures are episodes of abnormal electrical activity in the brain that can cause changes in behavior, movements, or consciousness. Neurologic abnormalities refer to any abnormality or dysfunction of the nervous system, which can manifest as developmental delays, movement disorders, or cognitive impairments.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify genetic variations or mutations. In the context of the CACNA1D gene, NGS genetic testing can be used to identify any variations or mutations in this gene that may be associated with primary aldosteronism, seizures, or neurologic abnormalities. This can help in diagnosing these conditions and guiding appropriate treatment or management strategies.

SKU: TEST-3767 Category:

Related products